Novartis | Australian Biotech Company News

Home Tags Novartis

Biotechnology

Update: Novartis’ Gene Therapy Zolgensma Gets Nod from EU

BioChannel - May 19, 2020

Biotechnology

Update: FDA Imposes No Penalties for Novartis Data Manipulation Scandal

BioChannel - April 2, 2020

Biotechnology

Novartis Enters RNA Therapeutics with Medicines Company Merger

BioChannel - November 25, 2019

Biotechnology

European Project Launches to Tailor Autoimmune Disease Treatments

BioChannel - October 31, 2019

Biotechnology

Trial Testing Spinal Application of Zolgensma Put on Hold by FDA

BioChannel - October 30, 2019

Biotechnology

Top Cardiology Biotech News from the ESC Conference 2019

BioChannel - September 5, 2019

Biotechnology

FDA Considers Imposing Penalties on Novartis over Data Manipulation

BioChannel - August 7, 2019

Biotechnology

Gilead Grows Antiviral Pipeline with Novartis, DURECT Licensing Deals

BioChannel - July 23, 2019

Biotechnology

Update: Novartis’ Neurological Gene Therapy Receives FDA Approval

BioChannel - May 24, 2019

Stay connected

Recent posts

Life in the Time of Coronavirus

BioChannel - July 10, 2020

Study pinpoints brain cells that trigger sugar cravings and consumption

BioChannel - July 10, 2020

Life Sciences Fund Launches with €76M to Invest in Nordic Biotech

BioChannel - July 10, 2020

Random article

Life in the Time of Coronavirus

Study pinpoints brain cells that trigger sugar cravings and consumption

Life Sciences Fund Launches with €76M to Invest in Nordic Biotech

VarmX bags €32m in Series B round – European Biotechnology News